Nexstim Plc (HEL:NXTMH)
Finland flag Finland · Delayed Price · Currency is EUR
8.10
+0.20 (2.53%)
Apr 2, 2025, 10:00 AM EET

Nexstim Company Description

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.

The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head.

It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NBS 6 and NBT, a navigated brain therapy systems for the treatment of major depressive disorder and chronic neuropathic pain.

The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. to develop, manufacture, and supply y Sinaptica’s patented precision neuromodulation device based on the Nexstim NBS 6 medical TMS and neuronavigation systems and related software; and a development and distribution collaboration with Brainlab AG for the development of solutions for non-invasive mapping of specific parts of the brain and Brainlab’s role as a distributor for certain Nexstim products.

The company was incorporated in 2000 and is headquartered in Helsinki, Finland.

Nexstim Plc
Nexstim logo
Country Finland
Founded 2000
Industry Medical Devices
Sector Healthcare
Employees 40
CEO Mikko Karvinen

Contact Details

Address:
Elimäenkatu 9 B
Helsinki, 00510
Finland
Phone 358 9272 7170
Website nexstim.com

Stock Details

Ticker Symbol NXTMH
Exchange Nasdaq Helsinki
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FI4000506811
SIC Code 3845

Key Executives

Name Position
Mikko Karvinen Chief Executive Officer
Joonas Juokslahti Chief Financial Officer
Henri Hannula Chief Commercial Officer